NCT04544748 2024-03-06
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
Phase 1 Unknown
Clinical Trials
46 trialsNCT04401059 2023-12-27
SELECT-2
Hangzhou Normal University
Phase 4 Unknown
NCT06090214 2023-10-19
BLADE
University Hospital, Montpellier
Phase NA Unknown
NCT05964543 2023-07-28
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
Phase 1/2 Unknown
NCT03995017 2023-02-01
RiME
University of Kansas Medical Center
Phase 1/2 Unknown
NCT04483726 2022-08-22
DIPLOMA
University Hospital, Montpellier
Phase NA Unknown
NCT04667403 2022-04-28
PANTELO
Institut Cancerologie de l'Ouest
Phase NA Unknown
NCT02773524 2022-01-13
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
Phase 3 Unknown
NCT04699071 2021-10-21
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)
National University Hospital, Singapore
Phase 2 Unknown
NCT04739202 2021-03-29
IMMUNOGAST
Hospices Civils de Lyon
Phase 2 Unknown
NCT02795650 2021-02-26
AVATAR
Hospital Universitario de Fuenlabrada
Phase 2 Unknown
NCT02785757 2021-01-06
PROSPECT
Hospices Civils de Lyon
Phase NA Unknown
NCT04202601 2019-12-19
Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer
Peking University
Phase 1/2 Unknown
NCT01682772 2019-08-15
TOPARP
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT03634332 2019-05-07
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Pancreatic Cancer Research Team
Phase 2 Unknown
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03636685 2018-08-17
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
ChineseAMS
Phase 1/2 Unknown
NCT03591666 2018-07-19
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT02125240 2018-07-16
ICWIP
Betta Pharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT03402464 2018-01-18
Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02863471 2017-10-31
PanHIPEC
University Hospital Tuebingen
Phase 1/2 Unknown
NCT01952951 2017-09-13
PREPARE
National Cancer Center, Korea
Phase 2 Unknown
NCT03202199 2017-07-26
PACMI
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT01930864 2017-06-22
Metformin Plus Irinotecan for Refractory Colorectal Cancer
Barretos Cancer Hospital
Phase 2 Unknown
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02951637 2016-11-01
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Shanghai Chest Hospital
Phase 2 Unknown
NCT01927328 2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4 Unknown
NCT02741778 2016-04-18
Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Anhui Provincial Hospital
Phase NA Unknown
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01182246 2014-04-23
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Axcentua Pharmaceuticals AB
Phase 1/2 Unknown
NCT01984580 2013-11-14
Effect of Zinc on Barrett's Metaplasia
Main Line Health
Phase 1 Unknown
NCT01921699 2013-08-13
Macrophages Effect on Chemoresistance
Rambam Health Care Campus
Phase NA Unknown
NCT01739465 2013-02-26
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Guangzhou Medical University
Phase 2/3 Unknown
NCT01786278 2013-02-07
BRASTEGAC
Medical University of Lublin
Phase 2/3 Unknown
NCT01523015 2013-02-05
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
Medical University of Lublin
Phase 2/3 Unknown
NCT01502202 2012-06-20
Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers
National Cancer Center, Korea
Phase 2 Unknown
NCT01556815 2012-04-25
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01552967 2012-03-28
mXELOX
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Unknown
NCT01552980 2012-03-28
mSOX
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Unknown
NCT01286064 2011-01-31
Colorectal Cancer Detection by Means of Optical Fluoroscopy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Unknown
NCT00751543 2010-06-29
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
National Taiwan University Hospital
Phase NA Unknown
NCT01130233 2010-05-25
Randomized Trial on Robotic Assisted Resection for Rectal Cancer
The University of Hong Kong
Phase 3 Unknown
NCT00908336 2009-05-25
Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen
Hospital Arnau de Vilanova
Phase 2 Unknown
NCT00669370 2008-04-30
GAST-TaxXel
University of Turku
Phase 2 Unknown
NCT00201331 2005-12-16
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer
National Health Research Institutes, Taiwan
Phase 2 Unknown